Headlands Technologies LLC purchased a new position in Insulet Co. (NASDAQ:PODD – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 395 shares of the medical instruments supplier’s stock, valued at approximately $86,000. Other hedge funds and […]
abrdn plc cut its position in Insulet Co. (NASDAQ:PODD – Free Report) by 3.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 305,354 shares of the medical instruments supplier’s stock after selling 11,574 shares during the quarter. abrdn plc owned about […]
Insulet Co. (NASDAQ:PODD – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the fifteen ratings firms that are covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 1 year price […]
Impax Asset Management Group plc cut its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,451 shares of the medical instruments supplier’s stock after selling 216 shares during the period. […]
Impax Asset Management Group plc trimmed its position in Insulet Co. (NASDAQ:PODD – Free Report) by 13.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,451 shares of the medical instruments supplier’s stock after selling 216 shares during the period. Impax Asset Management Group plc’s holdings in Insulet were worth $315,000 as […]